Akebia Therapeutics Inc (AKBA)
Cost of Revenue
$44.96M
TTM · Period ending: · USD
AKBA Cost of Revenue
Latest reported$44.96Mperiod ending
Latest reported$44.96Mperiod ending
AKBA TTM Cost of Revenue ($0.00 → $44.96M)
TTM cost of revenue
High-resolution chart · PNG
AKBA cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 44,960,000 | |
| 44,455,000 | |
| 39,462,000 | |
| 47,610,000 | |
| 52,070,000 | |
| 50,449,000 | |
| 45,539,000 | |
| 43,839,000 | |
| 47,687,000 | |
| 56,673,000 | |
| 74,147,000 | |
| 52,387,000 | |
| 72,659,000 | |
| 73,975,000 | |
| 85,130,000 | |
| 119,948,000 | |
| 97,611,000 | |
| 131,506,000 | |
| 134,768,000 | |
| 129,868,000 | |
| 144,269,000 | |
| 266,390,000 | |
| 259,497,000 | |
| 242,706,000 | |
| 250,624,000 | |
| 113,677,000 | |
| 117,221,000 | |
| 114,874,000 | |
| 147,245,000 | |
| 181,493,000 | |
| 211,640,000 | |
| 272,337,000 | |
| 260,414,000 | |
| 232,248,000 | |
| 230,893,000 | |
| 195,946,000 | |
| 168,473,000 | |
| 155,599,000 | |
| 115,785,000 | |
| 125,366,000 | |
| 94,128,000 | |
| 63,251,000 | |
| 43,016,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |